Survival data for 299 patients with primary cutaneous lymphomas: A monocentre study

Acta Dermato-Venereologica

Volumn 91, Issue 5, 2011, Pages 521-525

  Hallermann, Christian ^a   Niermann, Christoph ^a   Fischer, Rudolf Josef ^a   Schulze, Hans Joachim ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

B cell; Cutaneous lymphoma; Prognosis; Survival; T cell

Indexed keywords

ADULT; ARTICLE; B CELL LYMPHOMA; CANCER SURVIVAL; CUTANEOUS T CELL LYMPHOMA; FEMALE; FOLLOW UP; HISTOLOGY; HUMAN; LARGE CELL LYMPHOMA; LYMPHOMATOID PAPULOSIS; MAJOR CLINICAL STUDY; MALE; MARGINAL ZONE LYMPHOMA; MYCOSIS FUNGOIDES; PRIMARY CUTANEOUS FOLLICLE CENTRE LYMPHOMA; PRIMARY CUTANEOUS LYMPHOMA; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; SEZARY SYNDROME; SKIN LYMPHOMA; WORINGER KOLOPP DISEASE;

ADULT; AGED; ANALYSIS OF VARIANCE; CHI-SQUARE DISTRIBUTION; DISEASE-FREE SURVIVAL; FEMALE; GERMANY; HUMANS; KAPLAN-MEIER ESTIMATE; LYMPHOMA, B-CELL; LYMPHOMA, B-CELL, MARGINAL ZONE; LYMPHOMA, LARGE B-CELL, DIFFUSE; LYMPHOMA, T-CELL, CUTANEOUS; LYMPHOMATOID PAPULOSIS; MALE; MIDDLE AGED; MYCOSIS FUNGOIDES; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SKIN NEOPLASMS; SURVIVAL RATE; TIME FACTORS;

EID: 80052008860     PISSN: 00015555     EISSN: None     Source Type: Journal    
DOI: 10.2340/00015555-1112     Document Type: Article

References (31)

1. zinzani PL, Quaglino P, Pimpinelle N, Berti E, Baliva G,Rupol S, et al. Correspondence - in reply. J Clin Oncol 2006; 24: 4041.
2. Willemze R, Jaffe ES, Burg G, Cerroni L, Berti E, Swerd-low SH, et al. WHO-EORTC classification for cutaneous lymphomas. Blood 2005; 105: 3768-3785.
3. Hallermann C, Kaune KM, Gesk S, Martin-Subero JI,Gunawan B, Griesinger F, et al. Molecular cytogenetic analysis of chromosomal breakpoints in the IGH, MYC, BCL6, and MALT1 gene loci in primary cutaneous B-cell lymphomas. J Invest Dermatol 2004; 123: 213-219
4. Hallermann C, Kaune KM, Siebert R, Vermeer MH, Tensen CP, Willemze R, et al. Chromosomal aberration patterns differ in subtypes of primary cutaneous B cell lymphomas. J Invest Dermatol 2004; 122: 1495-1502.
5. Hallermann C, Niermann C, Fischer RJ, Schulze HJ. New prognostic relevant factors in primary cutaneous diffuse large B-cell lymphomas. J Am Acad Dermatol 2007; 56: 588-597.
6. Hoefnagel JJ, Dijkman R, Basso K, Jansen PM, Hallermann C, Willemze R, et al. Distinct types of primary cutaneous large B-cell lymphoma identified by gene expression pro-filing. Blood 2005; 105: 3671-3678.
7. d'Amore F, Christensen BE, Brincker H, Pedersen NT,Thorling K, Hastrup J, et al. Clinicopathological features and prognostic factors in extranodal non-Hodgkin lymphomas. Danish LYFO Study Group. Eur J Cancer 1991;27: 1201-1208.
8. Wilkins K, Turner R, Dolev JC, LeBoit PE, Berger TG,Maurer TA. Cutaneous malignancy and human immune-deficiency virus disease. J Am Acad Dermatol 2006; 54: 189-206.
9. Fink-Puches R, zenahlik P, Bäck B, Smolle J, Kerl H,Cerroni L. Primary cutaneous lymphomas: applicability of current classification schemes (European Organization for Research and Treatment of cancer, World Health Organisation) based on clinicopathologic features observed in a large group of patients. Blood 2002; 99: 800-805.
10. Wood GS, Greenberg HL. Diagnosis, staging, and monitoring of cutaneous T-cell lymphoma. Dermatol Therapy 2003; 16: 269-275.
11. Gniadecki R, Lukowsky A. Monoclonal T-cell dyscrasia of undetermined significance associated with recalcitrant erythroderma. Arch Dermatol 2005; 141: 361-367
12. Burg G, Dummer R, Kempf W. Dyscrasias with "undetermined significance". Arch Dermatol 2005; 141: 382-383
13. Gilliam AC, Wood GS. Cutaneous lymphoid hyperplasias.Semin Cutan Med Surg 2000; 19: 133-141
14. Pimpinelli N, Olsen E, Santucci M, Vonderheid E, Haeffner AC, Stevens S, et al. Defining early mycosis fungoides. J Am Acad Dermatol 2005; 53: 1053-1063.
15. Burg G. Cutaneous lymphomas. Curr Probl Dermatol 1997;26: 141-183.
16. Scarisbrick JJ. Staging and management of cutaneous T-cell lymphoma. Clin Exp Dermatol 2006; 31: 181-186
17. Bunn Jr PA, Lamberg SI. Report on the committee on staging and classification of cutaneous T-cell lymphomas. Cancer Treat Rep 1979; 63: 725-728.
18. Wallace AB. The exposure treatment of burns. Lancet 1951;2: 501-504.
19. Smith BD, Smith GL, Cooper DL, Wilson LD. The cutaneous B-cell lymphoma prognostic index: a novel prognostic index derived from a population-based registry. J Clin Oncol 2005; 23: 3390-3395.
20. Parmar MKB, Machin D, editors. Survival analysis. A practical approach. Chapter 6, Chichester: John Wiley and Sons, Inc., 1995. p 115-139.
21. Dores GM, Anderson WF, Devesa SS. Cutaneous lymphomas reported to the National Cancer Institute's Surveillance, Epidemiology, and End-Results Program: applying the new WHO-European Organisation for Research and Treatment of Cancer Classification System. J Clin Oncol 2005; 17: 7246-7247.
22. Gurney KA, Cartwright RA. Increasing incidence and descriptive epidemiology of extranodal non-Hodgkin lymphoma in parts of England and Wales. Haematol J 2002; 3: 95-104.
23. Newton R, Ferlay J, Berlal V, Devesa SS. The epidemiology of non-Hodgkin's lymphoma: comparison of nodal and extra-nodal sites. Int J Cancer 1997; 72: 923-930
24. Willemze R, Kerl H, Sterry W, Berti E, Cerroni L, Chimenti S, et al. EORTC classification for primary cutaneous lymphomas: a proposal from the cutaneous Lymphoma Study Group of the European Organization for Research and Treatment of Cancer. Blood 1997; 90: 354-371
25. Burg G. Cutaneous lymphomas. Curr Probl Dermatol 1997;26: 141-183.
26. Smith BD, Wilson LD. Management of mycosis fungoides:Part 1. Diagnosis, staging and prognosis. Oncology 2003; 17: 1281-1288.
27. zinzani PL, Quaglino P, Pimpinelle N, Berti E, Baliva G,Rupol S, et al. Prognostic factors in primary cutaneous B-cell lymphoma: the Italian Study Group for cutaneous lymphomas. J Clin Oncol 2006; 24: 1376-1382.
28. Diamandidou E, Colome-Grimmer M, Fayad L, Duvic M, Kurzrock R. Prognostic factor analysis in mycosis fungoides/Sezary syndrome. J Am Acad Dermatol 1999; 40: 914-924.
29. Kim YH, Bishop K, Varghese A, Hoppe RT. Prognostic factors in erythrodermic mycosis fungoides and the Sézary syndrome. Arch Dermatol 1995; 131: 1003-1008
30. Grange F, Hedelin G, Joly M, Beylot-Barry M, Incan DM,Delaunay M, et al. Prognostic factors in primary cutaneous lymphomas other than mycosis fungoides and the Sezary syndrome. Blood 1999; 93: 3637-3642.
31. Bouaziz JD, Bastuji-Garin S, Poszepczynska-Guigné E,Wechsler J, Bagot M. Relative frequency and survival of patients with primary cutaneous lymphomas: data from a single-centre study of 203 patients. Br J Dermatol 2006;154: 1206-1207.